Not applicableStudy completedNCT02491957What this trial is testingImpact of LOFT Therapy™ on Breast Cancer SurvivorsWho this might be right forBreast Neoplasms Kathy Miller 15
Not applicableWithdrawnNCT04583553What this trial is testingComparative Microbial Analysis of Cystitis in Non-muscle-invasive Bladder Cancer Patients Using Vikor Scientific Urine-ID Testing Menu (IDTM) and Standard Laboratory CultureWho this might be right forUrinary Tract InfectionsBladder Cancer University of Kansas Medical Center
Large-scale testing (Phase 3)UnknownNCT01320319What this trial is testingEffect of EPA on Aerobic Performance, Muscle, and Quality of Life in Colorectal Cancer Surgery PatientsWho this might be right forColorectal Cancer University of Nottingham 70
Not applicableUnknownNCT05263557What this trial is testingDissecting the IMpact of 11-OXygenated and Classic Androgens on Skeletal Muscle Insulin Sensitivity (DIMOXIS)Who this might be right forPolycystic Ovary SyndromeInsulin ResistanceAndrogen; Hypersecretion+1 more Royal College of Surgeons, Ireland 20
Not applicableUnknownNCT04192812What this trial is testingPREOPERATIVE GONADOTROPINE-RELEASING HORMONE AGONIST THERAPY BEFORE SURGERY FOR UTERİN FIBROIDSWho this might be right forUterine FibroidGonadotropin-Releasing Hormone-Dependent Precocious Puberty Alkü Alanya Education and Research Hospital 100
Not applicableStudy completedNCT00131365What this trial is testingMagnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine FibroidsWho this might be right forLeiomyoma InSightec 9
Testing effectiveness (Phase 2)Study completedNCT00041236What this trial is testingExatecan Mesylate in Treating Patients With Advanced Soft Tissue SarcomaWho this might be right forSarcoma European Organisation for Research and Treatment of Cancer - EORTC 39
Testing effectiveness (Phase 2)Looking for participantsNCT07579195What this trial is testingConsolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE TrialWho this might be right forMuscle Invasive Bladder CarcinomaStage III Bladder Cancer AJCC v8Stage IV Bladder Cancer AJCC v8 University of Washington 12
Not applicableStudy completedNCT03841981What this trial is testingBody Fat as Determinant of Female Gonadal DysfunctionWho this might be right forPolycystic Ovary SyndromeHypothalamic Amenorrhea Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 50
Not applicableLooking for participantsNCT07202819What this trial is testingEffect of Neoadjuvant Chemotherapy on MRI Accuracy Before CystectomyWho this might be right forMuscle Invasive Bladder Cancer Assiut University 76
Not applicableStudy completedNCT04683536What this trial is testingBakircay University Cigli Training and Research HospitalWho this might be right forBladder Cancer Recep Tayyip Erdogan University Training and Research Hospital 106
Large-scale testing (Phase 3)Study completedNCT02695771What this trial is testingThe Bladder Instillation Comparison StudyWho this might be right forUrinary Bladder Neoplasms Corewell Health West 101
Not applicableUnknownNCT02402075What this trial is testingSpinal Motor Evoked Potentials in Brain SurgeryWho this might be right forBrain TumorGlioma Heinrich-Heine University, Duesseldorf 40
Early research (Phase 1)Study completedNCT00020267What this trial is testingVaccine Therapy in Treating Patients With Metastatic CancerWho this might be right forLung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT04579133What this trial is testingNeoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical CystectomyWho this might be right forBladder CancerUrothelial Carcinoma Latin American Cooperative Oncology Group 140
Testing effectiveness (Phase 2)UnknownNCT05996952What this trial is testingRC48-ADC in Adjuvant/Salvage Treatment of HER2 Positive Non-muscle-invasive Bladder CancerWho this might be right forNon-muscle Invasive Bladder Cancer West China Hospital 77
Testing effectiveness (Phase 2)UnknownNCT04799847What this trial is testingCatumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG VaccineWho this might be right forBladder Cancer LintonPharm Co.,Ltd. 161
Testing effectiveness (Phase 2)Study completedNCT01920191What this trial is testingPhase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in GlioblastomaWho this might be right forCNS Tumor, Adult University Hospital, Geneva 19
Large-scale testing (Phase 3)Study completedNCT02560584What this trial is testingBlue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance SettingWho this might be right forBladder Cancer Photocure 304
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652What this trial is testingEnsartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more National Cancer Institute (NCI) 13